2016
DOI: 10.1080/15384101.2016.1218103
|View full text |Cite
|
Sign up to set email alerts
|

Why is an energy metabolic defect the common outcome in BMFS?

Abstract: Inherited bone marrow failure syndromes (BMFS) are rare, distressing, inherited blood disorders of children. Although the genetic origin of these pathologies involves genes with different functions, all are associated with progressive haematopoietic impairment and an excessive risk of malignancies. Defects in energy metabolism induce oxidative stress, impaired energy production and an unbalanced ratio between ATP and AMP. This assumes an important role in self-renewal and differentiation in haematopoietic stem… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 41 publications
0
3
0
Order By: Relevance
“…As mentioned above, MET has been tested in several diseases with the aim of reducing oxidative stress and improving the energetic/glucose metabolism (Hou et al, ; Khallaghi et al, ; Victor et al, ). Herein, we tested the effect of MET on Fanconi Anaemia because this pathology is characterized by an impairment of OXPHOS machinery due to a failed electron transport between complexes I and III (Cappelli et al, ; Degan et al, ; Ravera et al, ). Our attempt to use MET on FA cells shows that, although low concentrations of MET (15 and 150 μM) induce an increase in mitochondrial mass, the respiratory ability and the ATP/AMP ratio improve only poorly, as does the response to insulin stimuli and to oxidative stress.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As mentioned above, MET has been tested in several diseases with the aim of reducing oxidative stress and improving the energetic/glucose metabolism (Hou et al, ; Khallaghi et al, ; Victor et al, ). Herein, we tested the effect of MET on Fanconi Anaemia because this pathology is characterized by an impairment of OXPHOS machinery due to a failed electron transport between complexes I and III (Cappelli et al, ; Degan et al, ; Ravera et al, ). Our attempt to use MET on FA cells shows that, although low concentrations of MET (15 and 150 μM) induce an increase in mitochondrial mass, the respiratory ability and the ATP/AMP ratio improve only poorly, as does the response to insulin stimuli and to oxidative stress.…”
Section: Discussionmentioning
confidence: 99%
“…Fanconi Anemia is a genetic bone marrow failure syndrome with a high disposition to leukemia and other cancers (de Winter & Joenje, ). Although the DNA repair defect has a primary role in cellular phenotype, FA cells also show a respiratory chain defect, which causes an energetic impairment and an increase in the oxidative stress production (Degan, Ravera, & Cappelli, ; Ravera et al, ). Moreover, the oxidative stress causes FA insulin resistance and glucose metabolism related disorders (Li et al, ), which are present in about the 50% of FA patients (Elder et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…In conclusion, we believe that the evaluation of the energy metabolism alterations could open new horizons for FA patients diagnosis and therapy. This can also hold true for other bone marrow failure diseases, which share with FA some common features [10].…”
mentioning
confidence: 88%